ArticleScientific reports2023

Metronomic and single high-dose paclitaxel treatments produce distinct heterogenous chemoresistant cancer cell populations.

Carolina Mejia Peña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.